𝔖 Bobbio Scriptorium
✦   LIBER   ✦

R-CHOP therapy alone in limited stage diffuse large B-cell lymphoma

✍ Scribed by Tomita, Naoto; Takasaki, Hirotaka; Miyashita, Kazuho; Fujisawa, Shin; Ogusa, Eriko; Matsuura, Shiro; Kishimoto, Kumiko; Numata, Ayumi; Fujita, Atsuko; Ohshima, Rika; Kuwabara, Hideyuki; Hagihara, Maki; Hashimoto, Chizuko; Takemura, Sachiya; Koharazawa, Hideyuki; Yamazaki, Etsuko; Fujimaki, Katsumichi; Taguchi, Jun; Sakai, Rika; Ishigatsubo, Yoshiaki


Book ID
120227081
Publisher
John Wiley and Sons
Year
2013
Tongue
English
Weight
146 KB
Volume
161
Category
Article
ISSN
0007-1048

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


CHOP Chemotherapy plus Rituximab Compare
✍ Coiffier, Bertrand; Lepage, Eric; BriΓ¨re, Josette; Herbrecht, Raoul; Tilly, Herv πŸ“‚ Article πŸ“… 2002 πŸ› Massachusetts Medical Society 🌐 English βš– 116 KB

## Background The standard treatment for patients with diffuse large-B-cell lymphoma is cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP). Rituximab, a chimeric monoclonal antibody against the CD20 B-cell antigen, has therapeutic activity in diffuse large-B-cell lymphoma. We conduct